iDILI - Studies


Translational Safety Biomarker Pipeline (TransBioLine) Project, a five-year program to generate exploratory and confirmatory data supporting regulatory qualification and acceptance of novel safety biomarkers for five target organ systems (kidney, liver, pancreas, vascular and central nervous system) for application in drug development


Clinical Study:

Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity


RECRUITING (until 6th of March 2017)

Clinical Study:

Prospective European Drug-Iinduced Liver Injury Registry – PRO-EURO-DILI REGISTRY


RECRUITING (Status 3rd of March 2016)

Research Project:

Personalized Liver Protection (PerLiPro)

funded by m4-Award (STMWiVT Grant No. 1330/68362/34/2013)

Aim: Use oh MetaHeps® to discover novel iDILI biomarkers